These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8466214)

  • 21. A combination of livedo racemosa, occlusion of cerebral blood vessels, and nephropathy: kidney involvement in Sneddon's syndrome.
    Ohtani H; Imai H; Yasuda T; Wakui H; Komatsuda A; Hamai K; Miura AB
    Am J Kidney Dis; 1995 Sep; 26(3):511-5. PubMed ID: 7645561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sneddon's syndrome.
    Stephens CJ
    Clin Exp Rheumatol; 1992; 10(5):489-92. PubMed ID: 1458702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sneddon's syndrome: its clinical characteristics and etiopathogenic factors].
    Sempere AP; Martínez B; Bermejo F; Tahoces ML; Cabello A
    Rev Clin Esp; 1992 Jun; 191(1):3-7. PubMed ID: 1631358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristic imaging features of neurovascular involvement in primary Sneddon's syndrome: an analysis of 12 cases.
    Yilmaz E; Arsava EM; Gocmen R; Oguz KK; Arat A; Topcuoglu MA
    Neurol Sci; 2021 Jun; 42(6):2363-2369. PubMed ID: 33047201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Sneddon's syndrome: clinical, hematologic, and radiographic findings in two brothers.
    Pettee AD; Wasserman BA; Adams NL; McMullen W; Smith HR; Woods SL; Ratnoff OD
    Neurology; 1994 Mar; 44(3 Pt 1):399-405. PubMed ID: 8145905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Livedo reticularis and cerebrovascular lesions (Sneddon's syndrome). Clinical, radiological and pathological features in eight cases.
    Rebollo M; Val JF; Garijo F; Quintana F; Berciano J
    Brain; 1983 Dec; 106 ( Pt 4)():965-79. PubMed ID: 6652469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life history of cutaneous vascular lesions in Sneddon's syndrome.
    Zelger B; Sepp N; Schmid KW; Hintner H; Klein G; Fritsch PO
    Hum Pathol; 1992 Jun; 23(6):668-75. PubMed ID: 1592390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of anti-endothelial cell antibodies in patients with Sneddon's syndrome.
    Francès C; Le Tonquèze M; Salohzin KV; Kalashnikova LA; Piette JC; Godeau P; Nasonov EL; Youinou P
    J Am Acad Dermatol; 1995 Jul; 33(1):64-8. PubMed ID: 7601948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sneddon's syndrome and renal carcinoma. Case report.
    Carella F; Fetoni V; Pollo B; Testa D; Tagliavini F; Girotti F
    Funct Neurol; 1992; 7(5):395-400. PubMed ID: 1292961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sneddon's syndrome: a systemic arterio-occlusive disorder.
    al Meshari K; al Eisa A; Akhtar M
    Am J Kidney Dis; 1995 Aug; 26(2):368-72. PubMed ID: 7645543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sneddon syndrome: 9 cases].
    Antoine JC; Michel D; Garnier P; Absi L; Boucheron S; Barral FG; Laurent B
    Rev Neurol (Paris); 1994; 150(6-7):435-43. PubMed ID: 7747011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial Sneddon's syndrome.
    Lossos A; Ben-Hur T; Ben-Nariah Z; Enk C; Gomori M; Soffer D
    J Neurol; 1995 Feb; 242(3):164-8. PubMed ID: 7751860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sneddon's syndrome: generalized livedo reticularis and cerebrovascular disease. Importance of hemostatic screening.
    Devos J; Bulcke J; Degreef H; Michielsen B
    Dermatology; 1992; 185(4):296-9. PubMed ID: 1477426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Z deficiency in antiphospholipid-negative Sneddon's syndrome.
    Ayoub N; Esposito G; Barete S; Soria C; Piette JC; Francès C
    Stroke; 2004 Jun; 35(6):1329-32. PubMed ID: 15105516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrovascular lesions and livedo reticularis (Sneddon's syndrome)--a progressive cerebrovascular disorder?
    Rumpl E; Neuhofer J; Pallua A; Willeit J; Vogl G; Stampfel G; Platz T
    J Neurol; 1985; 231(6):324-30. PubMed ID: 3973641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sneddon syndrome as a clinical manifestation of the antiphospholipid antibody syndrome].
    Mojzes J; Battyáni Z; Grexa E
    Orv Hetil; 1993 Jan; 134(5):251-5. PubMed ID: 8426732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sneddon's syndrome: a comprehensive review of the literature.
    Wu S; Xu Z; Liang H
    Orphanet J Rare Dis; 2014 Dec; 9():215. PubMed ID: 25551694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sneddon's syndrome and phospholipid antibodies.
    Mesa HA; Lang B; Schumacher M; Vaith P; Peter HH
    Clin Rheumatol; 1993 Jun; 12(2):253-6. PubMed ID: 8358989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sneddon's syndrome: another migraine-stroke association?
    Tietjen GE; Al-Qasmi MM; Gunda P; Herial NA
    Cephalalgia; 2006 Mar; 26(3):225-32. PubMed ID: 16472327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.